Back to 
Skandinaviska Enskilda Banken AB (publ)
Skandinaviska Enskilda Banken AB (publ)
ANIP
Showing 0 of 9 quarters
Position history for Skandinaviska Enskilda Banken AB (publ)'s holdings in Ani Pharmaceuticals Inc
No. Skandinaviska Enskilda Banken AB (publ) exited its ANIP (Ani Pharmaceuticals) position in Q1 2024. Its Q4 2023 13F listed 16,500 shares worth $909,810. Skandinaviska Enskilda Banken AB (publ) already held ANIP in its Q4 2018 13F, the earliest on record, and held it in 6 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.